New information on the clinical use of the parenteral form of fosfomycin is presented in the form of a review of medical periodicals in the article "Phosfomycin for Injections: Still Effective, Still in Demand."

It is important to emphasize that fosfomycin successfully addresses the challenge of selecting a treatment for infections caused by multidrug-resistant bacteria, while ensuring optimal safety and tolerability of therapy. The versatility of the drug is also noteworthy, as it can be used for both Gram-negative infections and infections caused by resistant Gram-positive cocci.